• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
NASDAQ Composite
Standard & Poors 500
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

DaVita HealthCare Partner (NY:DVA)

182.17 +2.89 (+1.61%)
Delayed Quote Updated: 3:35 PM EST, Nov 11, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 317,120
Open 177.09
Bid (Size) 182.02 (300)
Ask (Size) 182.23 (100)
Prev. Close 179.28
Today's Range 177.09 - 182.17
52wk Range 101.00 - 247.49
Shares Outstanding 62,900,000
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of DaVita Inc. - DVA
November 10, 2026
From Pomerantz LLP
Via GlobeNewswire
News headline image
DaVita Sees Growth and Drug Savings Offsetting 2027 Reimbursement Pressure ↗
November 10, 2026
DaVita (NYSE:DVA) expects stronger dialysis treatment growth and pharmaceutical cost savings to help offset reimbursement pressures in 2027, though Chief Financial Officer Joel Ackerman said changes in... 
Via MarketBeat
Topics Artificial Intelligence

Performance

52-Week Range 26.4% below 52-week high
182.17
101.0052W Low 247.4952W High
1 Week 7.1% below 1-week high
177.471W Low 196.191W High

DaVita HealthCare Partner (DVA) traded between $101.00 and $247.49 over the past 52 weeks and last traded at $182.17, 26.4% below its 52-week high. Over the past week it ranged between $177.47 and $196.19.

Past 12 Months
-5.4%
+0.2%
+2.1%
-9.2%
+59.1%
+51.6%
1W -$10.49
1M +$0.39
3M +$3.83
6M -$18.37
YTD +$67.66
1Y +$62.00

DVA was +51.6% over the past year, -9.2% over six months, +59.1% year to date, -5.4% in the last week.

12 Months vs Market
DVA
+51.6%
DIA
+10.7%
SPY
+11.6%
QQQ
+10.9%
IWM
+16.0%

Over the past 12 months DVA returned +51.6% versus DIA (Dow) +10.7%, SPY (S&P 500) +11.6%, QQQ (Nasdaq 100) +10.9% and IWM (Russell 2000) +16.0%.

Volume & Liquidity 0.44× 3-mo avg
Today 317,120 3-mo avg 725.8K
1W
822.0K
1M
855.1K
3M
725.8K
6M
809.0K
YTD
895.5K
1Y
893.2K

DVA most recently traded 317,120 shares against a 3-month average daily volume of 725.8K.

More News

Read More
News headline image
Lowey Dannenberg, P.C. is Investigating DaVita Inc. (NYSE: DVA) for Potential Violations of the Federal Securities Laws
November 09, 2026
From Lowey Dannenberg, P.C.
Via GlobeNewswire
S&P 500 Top Movers: Gainers and Losers for Nov. 9, 2026 ↗
November 09, 2026
Via Chartmill
Topics Stocks
DaVita Inc. (NYSE:DVA) Q3 2026 EPS Beat Overshadowed by Nearly 10% After-Hours Drop ↗
October 29, 2026
Via Chartmill
News headline image
Did You Lose Money on DaVita Inc. Stock? The Law Offices of Howard G. Smith Announces Securities Fraud Investigation After 6.23% Share Price Decline
November 04, 2026
From The Law Offices of Howard G. Smith
Via Business Wire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of DaVita Inc. - DVA
November 03, 2026
From Pomerantz LLP
Via GlobeNewswire
News headline image
Lost Money on DaVita Inc. Shares? The Law Offices of Frank R. Cruz Investigates Potential Securities Fraud After 6.23% Stock Decline
November 03, 2026
From The Law Offices of Frank R. Cruz
Via Business Wire
S&P 500 Unusual Volume Movers for Oct. 30, 2026 ↗
October 30, 2026
Via Chartmill
Topics Stocks
News headline image
DVA Q3 deep dive: technology investment and integrated care strategy drive guidance shift
October 30, 2026
Via StockStory
News headline image
DaVita (DVA) Q3 2026 Earnings Call Transcript ↗
October 30, 2026
Via The Motley Fool
Topics Earnings
News headline image
What DaVita (DVA) Said on Its Q3 Earnings Call ↗
October 30, 2026
Via MarketBeat
Topics Artificial Intelligence Earnings
After-Hours S&P 500 Movers: Mondelez and FedEx Freight Gain, Intel and Reddit Fall ↗
October 29, 2026
Via Chartmill
Topics Stocks
News headline image
DaVita’s (NYSE:DVA) Q3 2026: beats on revenue but stock drops
October 29, 2026
Via StockStory
News headline image
DaVita earnings: what to look for from DVA
October 27, 2026
Via StockStory
Topics Artificial Intelligence
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of DaVita Inc. - DVA
October 27, 2026
From Pomerantz LLP
Via GlobeNewswire
News headline image
1 of Wall Street’s favorite stocks worth investigating and 2 we find risky
October 26, 2026
Via StockStory
News headline image
Outpatient & specialty care stocks Q2 teardown: DaVita (NYSE:DVA) vs the rest
October 21, 2026
Via StockStory
Topics Artificial Intelligence
News headline image
Why DaVita (DVA) Stock Is Nosediving
October 20, 2026
Via StockStory
Topics Government
S&P 500 Top Movers: EFX and HAS Lead Today's Gainers, GM and DVA Fall ↗
October 20, 2026
Via Chartmill
Topics Stocks
S&P 500 Unusual Volume Movers for October 20 ↗
October 20, 2026
Via Chartmill
Topics Stocks
S&P 500 Top Movers: Gainers and Losers From Today's US Session ↗
October 20, 2026
Via Chartmill
Topics Stocks
News headline image
1 Mid-Cap Stock to Target This Week and 2 Facing Headwinds
October 12, 2026
Via StockStory
News headline image
3 Berkshire Hathaway Holdings to Buy While They Sit at Least 15% Below Their Highs ↗
October 06, 2026
Via The Motley Fool
Topics Artificial Intelligence
News headline image
3 Cash-Producing Stocks with Open Questions
September 30, 2026
Via StockStory

Frequently Asked Questions

Is DaVita HealthCare Partner publicly traded?
Yes, DaVita HealthCare Partner is publicly traded.
What exchange does DaVita HealthCare Partner trade on?
DaVita HealthCare Partner trades on the New York Stock Exchange
What is the ticker symbol for DaVita HealthCare Partner?
The ticker symbol for DaVita HealthCare Partner is DVA on the New York Stock Exchange
What is the current price of DaVita HealthCare Partner?
The current price of DaVita HealthCare Partner is 182.17
When was DaVita HealthCare Partner last traded?
The last trade of DaVita HealthCare Partner was at 11/11/26 03:35 PM ET
What is the market capitalization of DaVita HealthCare Partner?
The market capitalization of DaVita HealthCare Partner is 11.46B
How many shares of DaVita HealthCare Partner are outstanding?
DaVita HealthCare Partner has 11B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap